A biomarker trial of BR-DIM (BioResponse 3,3′-Diindolylmethane) in patients with prostate cancer who undergo prostatectomy.

被引：0
|
作者：
Heath, E. I.
Hwang, C.
Cher, M. L.
Heilbrun, L. K.
Powell, I.
Menon, M.
Li, J.
Heath, M.
Sethi, S.
Sarkar, F. H.
机构：
[1] Karmanos Canc Inst, Detroit, MI USA
[2] Henry Ford Hosp, Detroit, MI 48202 USA
[3] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e15185
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15185
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway
    M Nachshon-Kedmi
    S Yannai
    F A Fares
    British Journal of Cancer, 2004, 91 : 1358 - 1363
  • [32] Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3′-diindolylmethane through the mitochondrial pathway
    Nachshon-Kedmi, M
    Yannai, S
    Fares, FA
    BRITISH JOURNAL OF CANCER, 2004, 91 (07) : 1358 - 1363
  • [33] Effects of Sulforaphane and 3,3′-Diindolylmethane on Genome-Wide Promoter Methylation in Normal Prostate Epithelial Cells and Prostate Cancer Cells
    Wong, Carmen P.
    Hsu, Anna
    Buchanan, Alex
    Palomera-Sanchez, Zoraya
    Beaver, Laura M.
    Houseman, E. Andres
    Williams, David E.
    Dashwood, Roderick H.
    Ho, Emily
    PLOS ONE, 2014, 9 (01):
  • [34] The Plant Derived 3-3′-Diindolylmethane (DIM) Behaves as CB2 Receptor Agonist in Prostate Cancer Cellular Models
    Tucci, Paolo
    Brown, Iain
    Bewick, Guy S. S.
    Pertwee, Roger G. G.
    Marini, Pietro
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [35] Inactivation of uPA and its receptor uPAR by 3, 3\#8217;-Diindolylmethane (DIM) leads to the inhibition of prostate cancer cell growth and migration
    Ahmad, Aamir
    Kong, Dejuan
    Sarkar, Sanila
    Wang, Zhiwei
    Banerjee, Sanjeev
    Sarkar, Fazlul
    CANCER RESEARCH, 2009, 69
  • [36] 3,3'-Diindolylmethane(DIM), a dietary indole, has multiple cell suppressive effects on MCF-7, human breast cancer cells
    Hong, C
    Firestone, GL
    Bjeldanes, LF
    MOLECULAR BIOLOGY OF THE CELL, 2000, 11 : 38A - 38A
  • [37] The effects of 3,3′-diindolylmethane and genistein on estrogen induced proliferation and estrogen metabolism in human prostate cancer cell lines
    Smith, Sunyata
    Auborn, Karen J.
    CANCER RESEARCH, 2006, 66 (08)
  • [38] 3,3-Diindolylmethane (DIM): a nutritional intervention and its impact on breast density in healthy BRCA carriers. A prospective clinical trial
    Yerushalmi, Rinat
    Bargil, Sharon
    Ber, Yaara
    Ozlavo, Rachel
    Sivan, Tuval
    Rapson, Yael
    Pomerantz, Adi
    Tsoref, Daliah
    Sharon, Eran
    Caspi, Opher
    Grubsrein, Ahuvah
    Margel, David
    CARCINOGENESIS, 2020, 41 (10) : 1395 - 1401
  • [39] A randomized phase II trial of neoadjuvant chemokine modulation in patients with localized prostate cancer undergoing radical prostatectomy.
    Jatwani, Karan
    Kalathil, Suresh
    Slomba, Ronald
    Farmer, Bailey
    Attwood, Kristopher
    Roy, Arya Mariam
    Singh, Prashant
    Kauffman, Eric
    Gopalakrishnan, Dharmesh
    George, Saby
    Levine, Ellis Glenn
    Guru, Khurshid
    Kalinski, Pawel
    Chatta, Gurkamal S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [40] A randomized phase II trial of neoadjuvant chemokine modulation in patients with localized prostate cancer undergoing radical prostatectomy.
    Jatwani, Karan
    Farmer, Bailey
    Roy, Arya Mariam
    Slomba, Ronald
    Attwood, Kristopher
    Levine, Ellis Glenn
    Kauffman, Eric
    Kalinski, Pawel
    Guru, Khurshid
    Gopalakrishnan, Dharmesh
    Chatta, Gurkamal S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345